AVIVA PLC

Position in EXEL — Exelixis, Inc.

CIK 1140022 LONDON, X0

Position in EXEL

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$1,078,812

-$47,881 QoQ

Shares Held

25,153

-2.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

AVIVA PLC holds $267,602,543 across 25 Biotechnology names. EXEL ranks #8 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	222,452	$99,333,716
2	REGN	Regeneron Pharmaceuticals, Inc.	91,176	$70,446,224
3	ALNY	Alnylam Pharmaceuticals, Inc.	114,003	$37,720,172
4	INSM	INSMED Inc	122,074	$19,961,540
5	RPRX	Royalty Pharma plc	323,823	$15,533,789
6	INCY	Incyte Corp	148,088	$13,938,042
7	RVMD	Revolution Medicines, Inc.	21,460	$2,086,985
8	EXEL	Exelixis, Inc. This page	25,153	$1,078,812

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,078,812	25,153	-2.2%	Shares	Defined	2026-05-14
2025-12-31	$1,126,693	25,706	-4.3%	Shares	Defined	2026-02-12
2025-09-30	$1,109,318	26,860	+15.6%	Shares	Defined	2025-11-13
2025-06-30	$1,024,551	23,243	+44.0%	Shares	Defined	2025-08-07
2025-03-31	$595,814	16,138	-6.3%	Shares	Defined	2025-05-15
2024-12-31	$573,692	17,228	-30.9%	Shares	Defined	2025-02-13
2024-09-30	$646,855	24,927	-54.2%	Shares	Defined	2024-11-14
2021-03-31	$1,230,273	54,461	+10.7%	Shares	Defined	2021-05-13
2020-12-31	$987,022	49,179	-44.8%	Shares	Defined	2021-02-10
2020-09-30	$2,177,199	89,047	-11.4%	Shares	Defined	2020-11-12
2020-06-30	$2,385,347	100,478	-52.3%	Shares	Defined	2020-08-13
2020-03-31	$3,630,285	210,818	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.